Research interests include clinical and translational research in new drug development, gastrointestinal and genito-urinary malignancies. Dr. Knox is also the Principal Investigator of trials in biliary, hepatocellular, esophageal and renal cell cancers.
Jennifer J Knox
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer - Early Results from the COMPASS Trial.
Clin Cancer Res. 2017 Dec 29;:
Curr Probl Cancer. 2017 Nov 16;:
Curr Probl Cancer. 2017 Nov 14;:
Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre Experience.
Clin Colorectal Cancer. 2017 Oct 23;:
Surg Oncol Clin N Am. 2017 Oct;26(4):647-666
Mol Carcinog. 2017 Sep 11;:
Cell Immunol. 2017 Jul 11;:
J Gastrointest Oncol. 2017 Apr;8(2):352-360
Oncotarget. 2017 03 03;:
Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial.
Dis Esophagus. 2016 Nov;29(8):1152-1158
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Associate Professor, Department of Medicine, University of Toronto
Chair, Kidney Disease Oriented Group, National Cancer Institute of Canada
Chair, Hepatobiliary Disease Oriented Group, National Cancer Institute of Canada